Non–Small Cell Lung Cancer: Other Actionable Mutations
2 意见
• 07/04/23
0
0
嵌入
Corey J. Langer, MD; V****iliki Papadimitrakopoulou, MD; and Hossein Borghaei, DO, elucidate the potential value of less common actionable mutations in determining appropriate treatment for patients with non–small cell lung cancer.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论